| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
AEBP1
|
AE binding protein 1
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIM2
|
absent in melanoma 2
|
|
ALB
|
albumin
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ATOH7
|
atonal homolog 7 (Drosophila)
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CALB2
|
calbindin 2
|
|
CASC3
|
cancer susceptibility candidate 3
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD24
|
CD24 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD82
|
CD82 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CHGA
|
chromogranin A
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLDN1
|
claudin 1
|
|
CLDN4
|
claudin 4
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A1P
|
cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FAM20A
|
family with sequence similarity 20, member A
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGF17
|
fibroblast growth factor 17
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL5
|
four and a half LIM domains 5
|
|
FN1
|
fibronectin 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXC2
|
forkhead box C2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FPR2
|
formyl peptide receptor 2
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GCG
|
glucagon
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNAS
|
GNAS complex locus
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPC3
|
glypican 3
|
|
GPX1
|
glutathione peroxidase 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK2
|
hexokinase 2
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL4
|
interleukin 4
|
|
IL9
|
interleukin 9
|
|
INHBA
|
inhibin, beta A
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRS4
|
insulin receptor substrate 4
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK15
|
kallikrein-related peptidase 15
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT75
|
keratin 75, type II
|
|
LAMC2
|
laminin, gamma 2
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MIR145
|
microRNA 145
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MT1A
|
metallothionein 1A
|
|
MT2A
|
metallothionein 2A
|
|
MT3
|
metallothionein 3
|
|
MTDH
|
metadherin
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAA11
|
N(alpha)-acetyltransferase 11, NatA catalytic subunit
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NTF4
|
neurotrophin 4
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUDC
|
nudC nuclear distribution protein
|
|
OCLN
|
occludin
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PDE11A
|
phosphodiesterase 11A
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POMC
|
proopiomelanocortin
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RHOD
|
ras homolog family member D
|
|
RLN1
|
relaxin 1
|
|
RLN2
|
relaxin 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRG
|
retinoid X receptor, gamma
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SCG5
|
secretogranin V
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SELE
|
selectin E
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STK11
|
serine/threonine kinase 11
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFF1
|
trefoil factor 1
|
|
TFF2
|
trefoil factor 2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFR2
|
transferrin receptor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM4
|
transglutaminase 4
|
|
THBS1
|
thrombospondin 1
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNXB
|
tenascin XB
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TUBA1B
|
tubulin, alpha 1b
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBG1
|
tubulin, gamma 1
|
|
TYMS
|
thymidylate synthetase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UMPS
|
uridine monophosphate synthetase
|
|
USP5
|
ubiquitin specific peptidase 5 (isopeptidase T)
|
|
VAT1
|
vesicle amine transport 1
|
|
VCAN
|
versican
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
